Elevated NRF2 levels in acute myeloid leukaemia reduces sensitivity towards proteasome inhibitors

Research output: Contribution to journal › Abstract › peer-review

Original language	English
Pages (from-to)	31
Number of pages	1
Journal	Basic & Clinical Pharmacology & Toxicology
Volume	109
DOIs	https://doi.org/10.1111/j.1742-7843.2011.00773.x
Publication status	Published - Oct 2011

Access to Document

@article{04ae062699344e0eacbf0ab2f60cae7d,

title = "Elevated NRF2 levels in acute myeloid leukaemia reduces sensitivity towards proteasome inhibitors",

author = "Rushworth, {S. A.} and Bowles, {K. M.} and MacEwan, {D. J.}",

year = "2011",

month = oct,

doi = "10.1111/j.1742-7843.2011.00773.x",

language = "English",

volume = "109",

pages = "31",

journal = "Basic & Clinical Pharmacology & Toxicology",

issn = "1742-7835",

publisher = "Wiley",

}

TY - JOUR

T1 - Elevated NRF2 levels in acute myeloid leukaemia reduces sensitivity towards proteasome inhibitors

AU - Rushworth, S. A.

AU - Bowles, K. M.

AU - MacEwan, D. J.

PY - 2011/10

Y1 - 2011/10

U2 - 10.1111/j.1742-7843.2011.00773.x

DO - 10.1111/j.1742-7843.2011.00773.x

M3 - Abstract

VL - 109

SP - 31

JO - Basic & Clinical Pharmacology & Toxicology

JF - Basic & Clinical Pharmacology & Toxicology

SN - 1742-7835

ER -